We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

100 hedge funds and large institutions have $60M invested in Precision BioSciences in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more call options, than puts

Call options by funds: $26K | Put options by funds: $14K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.04% less ownership

Funds ownership: 1.56% → 1.52% (-0.04%)

6% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 18

2% less funds holding

Funds holding: 102 → 100 (-2)

13% less capital invested

Capital invested by funds: $68.6M → $60M (-$8.63M)

40% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 35

Holders
100
Holders Change
-2
Holders Change %
-1.96%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
21
Reduced
35
Closed
18
Calls
$26K
Puts
$14K
Net Calls
+$12K
Net Calls Change
-$35K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$1.44M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$630K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$520K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$393K
5
Stifel Financial
Stifel Financial
Missouri
+$326K

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$1.8M
2
Millennium Management
Millennium Management
New York
-$1.12M
3
BlackRock
BlackRock
New York
-$874K
4
Renaissance Technologies
Renaissance Technologies
New York
-$780K
5
UOC
UBS O'Connor
Illinois
-$640K
Name Holding Trade Value Shares
Change 		Change in
Stake
ZIM
101
Zacks Investment Management
Illinois
– -$46K -1,182 Closed
VF
102
Virtu Financial
New York
– -$35K -886 Closed
QT
103
Quantbot Technologies
New York
– -$26K -669 Closed
Balyasny Asset Management
104
Balyasny Asset Management
Illinois
– -$25K -644 Closed
Allspring Global Investments
105
Allspring Global Investments
North Carolina
– -$24K -621 Closed
LP
106
LMR Partners
United Kingdom
– -$23K -601 Closed
SFI
107
Susquehanna Fundamental Investments
Pennsylvania
– -$19K -482 Closed
Two Sigma Advisers
108
Two Sigma Advisers
New York
– -$18K -463 Closed
Cetera Investment Advisers
109
Cetera Investment Advisers
Illinois
– -$15K -379 Closed
DFCM
110
Dark Forest Capital Management
Puerto Rico
– -$13K -330 Closed
Legal & General Group
111
Legal & General Group
United Kingdom
– -$6K -146 Closed
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
– -$1.62K -41 -85%
CUAMC
113
China Universal Asset Management Company
China
– -$1K -35 Closed
Citigroup
114
Citigroup
New York
– -$1K -33 Closed
SFG
115
Steward Financial Group
Texas
– +$119 +3 New
1 2 3 4
5

DTIL Hedge Fund Activity: Q4 2022 in Review

100 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2022, worth a combined $60M — down 13% from $68.6M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of DTIL and 17 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 21 added.

The largest buyer was Great Point Partners, adding an estimated $1.44M. The largest seller was Marshall Wace, cutting an estimated $1.8M.

  • 100 institutional investors held Precision BioSciences (DTIL) as of Q4 2022, down from 102 in Q3 2022.
  • Funds reported $60M of Precision BioSciences stock for Q4 2022, down 13% quarter-over-quarter.
  • 17 funds opened new Precision BioSciences positions in Q4 2022 and 18 closed out, a net change of -1 holder.
  • The largest Precision BioSciences buyer in Q4 2022 was Great Point Partners, an estimated $1.44M added.
  • The largest Precision BioSciences seller in Q4 2022 was Marshall Wace, an estimated $1.8M sold.

Based on aggregated 13F filings for Q4 2022.